Everolimus-Eluting Stents or Bypass Surgery for Multivessel Disease in Diabetics The BEST Extended Follow-Up Study
- Authors
- Kim, Hoyun; Kang, Do-Yoon; Ahn, Jung -Min; Lee, Jinho; Choi, Yeonwoo; Hur, Seung Ho; Park, Hun-Jun; Tresukosol, Damras; Kang, Woong Chol; Kwon, Hyuck Moon; Rha, Seung-Woon; Lim, Do-Sun; Jeong, Myung-Ho; Lee, Bong-Ki; Huang, He; Lim, Young-Hyo; Bae, Jang Ho; Kim, Byung Ok; Ong, Tiong Kiam; Ahn, Sung Gyun; Chung, Cheol-Hyun; Park, Duk-Woo; Park, Seung-Jung
- Issue Date
- Oct-2023
- Publisher
- W B SAUNDERS CO-ELSEVIER INC
- Keywords
- bypass surgery; coronary intervention; diabetes; multivessel disease; stent(s)
- Citation
- RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, v.16, no.19, pp 2412 - 2422
- Pages
- 11
- Journal Title
- RHEUMATIC DISEASE CLINICS OF NORTH AMERICA
- Volume
- 16
- Number
- 19
- Start Page
- 2412
- End Page
- 2422
- URI
- https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/90038
- DOI
- 10.1016/j.jcin.2023.07.028
- ISSN
- 0889-857X
1558-3163
- Abstract
- BACKGROUND Diabetes mellitus is associated with more complex coronary artery diseases. Coronary artery bypass grafting (CABG) is a preferred revascularization strategy over percutaneous coronary intervention (PCI) in diabetics with multivessel coronary artery disease (MVD).OBJECTIVES This study sought to examine the different prognostic effects of revascularization strategies according to the diabetes status from the randomized BEST (Randomized Comparison of Coronary Artery Bypass Surgery and Everolimus-Eluting Stent Implantation in the Treatment of Patients With Multivessel Coronary Artery Disease) trial.METHODS Patients (n = 880) with MVD were randomly assigned to undergo PCI with an everolimus-eluting stent vs CABG stratified by diabetics (n = 363) and nondiabetics (n = 517). The primary endpoint was the composite of death, myocardial infarction, or target vessel revascularization during a median follow-up of 11.8 years (IQR: 10.6-12.5 years).RESULTS In diabetics, the primary endpoint rate was significantly higher in the PCI group than in the CABG group (43% and 32%; HR: 1.53; 95% CI: 1.12-2.08; P = 0.008). However, in nondiabetics, no significant difference was found be-tween the groups (PCI group, 29%; CABG group, 29%; HR: 0.97; 95% CI: 0.67-1.39; P = 0.86; Pinteraction = 0.009). Irrespective of the presence of diabetes, no significant between-group differences were found in the rate of a safety composite of death, myocardial infarction, or stroke and mortality rate. However, the rate of any repeat revascularization was significantly higher in the PCI group than in the CABG group.CONCLUSIONS In diabetics with MVD, CABG was associated with better clinical outcomes than PCI. However, the mortality rate was similar between PCI and CABG irrespective of diabetes status during an extended follow-up. (Ten-Year Outcomes of Randomized Comparison of Coronary Artery Bypass Surgery and Everolimus-Eluting Stent Implantation in the Treatment of Patients With Multivessel Coronary Artery Disease [BEST Extended], NCT05125367; Randomized Comparison of Coronary Artery Bypass Surgery and Everolimus-Eluting Stent Implantation in the Treatment of Patients With Multivessel Coronary Artery Disease [BEST], NCT00997828) (J Am Coll Cardiol Intv 2023;16:2412-2422) (c) 2023 by the American College of Cardiology Foundation.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - ETC > 1. Journal Articles
![qrcode](https://api.qrserver.com/v1/create-qr-code/?size=55x55&data=https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/90038)
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.